ArticleERJ open research2026
Predictive models for mortality readmission events and cardiovascular complications in patients with COPD: a systematic review and meta-analysis.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: COPD is a major global health burden, associated with high rates of mortality, readmissions and cardiovascular disease (CVD) complications. Predictive models, including statistical and machine learning (ML) approaches, have been developed to support risk stratification and clinical decision-making. This review assesses their performance and generalisability. Methods: A systematic search of EMBASE, MEDLINE and PubMed identified studies published since 2015 evaluating predictive models for COPD-related outcomes. Studies were screened using predefined criteria, and model performance was synthesised Results: Of 3 488 records screened, 37 studies met inclusion criteria: 20 focused on mortality, 14 on readmissions and six on CVD complications. Statistical models had a pooled AUC of 0.787 (95% CI 0.755-0.816). For mortality, statistical models outperformed or matched ML models (AUC 0.801 Conclusions: ML models improve readmission prediction but offer no consistent advantage for mortality, where statistical models perform similarly. ML models face generalisability challenges due to overfitting. Future work should emphasise real-world validation and hybrid approaches to enhance interpretability and clinical applicability in COPD care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.